TARS SCHEDULE 13G/A: SEC filing
Paradigm BioCapital Advisors LP and affiliated reporting persons
Filed with the SEC on · accession 0001104659-26-128301
TARS filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -2.1% by the first close after the filing.
Summary of the filing
Paradigm BioCapital Advisors LP and affiliated reporting persons filed an amended Schedule 13G disclosing beneficial ownership of 2,301,375 shares (4.7%) of Tarsus Pharmaceuticals common stock as of September 30, 2026, on a passive basis.
Key details
How TARS stock reacted
Close before
$80.28
Nov 13, 2026
First close after
-2.06%
$78.63
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for TARS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TARS?
Click hereFrequently asked questions
What did TARS file with the SEC on Nov 16, 2026?
TARS filed a SCHEDULE 13G/A (SEC filing). Paradigm BioCapital Advisors LP and affiliated reporting persons filed an amended Schedule 13G disclosing beneficial ownership of 2,301,375 shares (4.7%) of Tarsus Pharmaceuticals common stock as of September 30, 2026, on a passive basis.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did TARS stock react to this filing?
TARS closed at $80.28 before the filing and $78.63 on Nov 16, 2026 (-2.06%).
Other TARS SEC filings
- SCHEDULE 13G · SEC filingNov 5, 2026
- 10-Q · SEC filingNov 3, 2026
- 8-K · SEC filingNov 3, 2026
- 8-K · SEC filingOct 13, 2026
- 8-K · AcquisitionSep 10, 2026
- SCHEDULE 13G/A · SEC filingAug 13, 2026
- 8-K · Guidance raiseAug 6, 2026
- 8-K · Secondary offeringAug 6, 2026
- 8-K · AcquisitionAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
Get alerts when TARS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days